AstraZeneca in Egypt
Welcome to AstraZeneca Egypt
AstraZeneca is a global, science-led pharmaceutical company driven by innovative science and entrepreneurial culture inspired by our purpose and values, we are transforming the future of healthcare by unlocking the power of what science can do- for people, society and the planet.
AstraZeneca Egypt has a solid presence in the Egyptian pharmaceutical market since 1968 and is engaged in the manufacture and supply of medicines that aim to make a real difference to the lives of Egyptians.
650+
Around 95M
Since 1968
Sustainable Headquarters in New Cairo
3 Sales offices
Local manufacturing site
Our Values and Behaviours
Our values determine how we work together and the behaviours that drive our success. They guide our decision making, define our beliefs and help foster a strong culture at AstraZeneca.
We follow
the science
Pushing the boundaries of science and working creatively with
partners and collaborators.
We put
patients first
Striving to understand patients’ needs and considering them in
every decision we take.
We play
to win
Building high-performing, inclusive and diverse teams and making
the right choices to win.
We do
the right thing
Employing high ethical standards when carrying out all aspects of
our business globally.
We are entrepreneurial
Acting with urgency, bravery, resilience and taking smart risks.
Our Therapy Areas
Unlocking the power of what science can do
Oncology
We push the boundaries of science to transform the lives of patients living with cancer, and ultimately eliminate cancer as a cause of death
Respiratory & Immunology
From mild to severe asthma to COPD, we help patients with respiratory illnesses to lead active lives
Cardiovascular, Renal and Metabolism
From prevention to treatment to improved survival, we empower patients with cardiovascular and metabolic diseases to do more
Vaccine & Immune Therapies
Helping to change the course of the pandemic by supplying 3 billion doses to more than 180 countries, saving 1m+ lives
Rare Disease
Transforming the lives of people affected by rare diseases and devastating conditions
Our Commitment to Patients
Our longstanding commitment to patients has led us to reimagine our patient-focused ways of working, as we embed it across every aspect of our company to deliver the healthcare experience and outcomes people care about most so they can enjoy fulfilling lives.
Our Partnerships and Projects in Egypt
Our Sustainability Approach
Our future depends on healthy people, a healthy society and a healthy planet. We believe that these elements are interconnected, and that together we must build a sustainable future.
As a global business, we are playing our part in tackling the biggest challenges of our time, from climate change to access to healthcare and disease prevention. We are harnessing the power of science and innovation and our global reach to make a positive impact on society, healthcare systems, and the environment. This starts with us, but matters to everyone, everywhere.
Our approach to sustainability has three interdependent and cooperative priorities :
AstraZeneca Egypt launches Direct Supply Model to enhance medicine availability for patients
Considering the relevant applicable laws and regulations in the Arab Republic of Egypt, its internal policies and ongoing commitment to improving patient access to healthcare, AstraZeneca Egypt for Pharmaceutical Industries S.A.E (“AstraZeneca”) hereby invites all retail pharmacies in Egypt to join its newly proposed direct supply model hereunder (“Model” or “Direct Supply Network”). This Model entails circulating AstraZeneca’s traded products in Egypt (“Products”) through direct supply to licensed and operating pharmacies (for private market).
This Model only intends to complement the Products circulation through AstraZeneca’s distributors, which shall remain in force. For the avoidance of doubt, neither AstraZeneca nor any responding pharmacy may claim distributor’s margin under this Model.
The main objective of this Model is to legitimately diversify and widen the circulation means of the Products in Egypt, in order to ensure efficiency of the Products' availability and geographical expansion; all with the aim of enhancing patients' access to the Products.
This Model aims to strengthen AstraZeneca’s supply chain and support pharmacies in delivering high-quality care to patients in every Egyptian governorate.
Through this announcement, AstraZeneca will be exploring a new business model that reaffirms its dedication to advancing health equity and ensuring that every patient has timely, consistent and reliable access to the treatments they need.
This document includes background material and provides guidelines to be followed when the responding pharmacies prepare their responses and proposals.
Information provided in this document is accurate on and as of the date of sending it out to pharmacies. This document is not an offer to contract, nor does it create any legal obligations on AstraZeneca or the responding pharmacies.
The provision of a proposal by responding pharmacies does not commit AstraZeneca to award a contract to any of them, even if all requirements stated in this document are satisfied, nor limits AstraZeneca’s right to negotiate for its best interest. Astrazeneca reserves the right to accept or reject all or any part of any or all responses to this document and to enter into discussions and/or negotiations with one or more of the responding pharmacies. Additionally, AstraZeneca reserves the right to amend or withdraw this document, in whole or in part, at any time with no liability of any kind.
AstraZeneca reserves the right to enter into a contract with responding pharmacies hereunder for reasons other than financial matters. The selection of pharmacies will be based upon the responses and proposals received to this document, which will form the basis for subsequent discussions and negotiations with the pre-selected pharmacies.
Therefore, responses should be submitted in the most favorable terms satisfying the proposal prerequisites and requirements.
The information, including financials, stated in your response must remain valid and accurate for three months from the date on which it is submitted to AstraZeneca.
Failure to answer any question or to meet any prerequisite or requirement in this document, may make the proposal subject to disqualification. Responding to this announcement constitutes an explicit acknowledgment, understanding and acceptance by responding pharmacies of all of the announcement’s content.
If you are interested in becoming part of AstraZeneca’s Direct Supply Network, please review this announcement thoroughly, and submit your response through the link below: (Pharmacy Direct Procurement Program)
Submission window:
Submissions will only be open from 20 August 2025 until 10 September 2026, Closing Date.
Please note that no new submissions will be accepted after the Closing Date.
Egypt Sustainability Green Strategy towards Decarbonization of
Healthcare Post-COP27 and Beyond
Green Hospitals
AstraZeneca announced our comprehensive approach towards Sustainability developed in partnership with the Egyptian Government and health authorities to mitigate the environmental burden of healthcare, and support sustainability and resilience. It reflects our commitment to accelerate the delivery of actions on climate for the benefit of people, society, and the planet. Through our Green Hospital initiative, we aim to accelerate the delivery of net zero, patient-centric healthcare. This mega 20-beds field mobile solar green hospital is serving all COP27 visitors and beyond.
Green Energy
Providing Electric vehicles charging stations inside the green hospitals
Green Minds
Continuous awareness raised through our Young Health Programme on climate-health links. We are aiming to reach 700,000 young people in 5 years
Green Supply/Site
External Awards Recognitions
AstraZeneca Egypt Awarded for the unprecedented growing business and sustainable development in our community towards the new republic
During the largest annual summit Amwal Al Ghad” to honor the most influential entities and people who impacted the Egyptian economy and society, under the slogan of “The new republic – a story of achievement and work” to celebrate the successes of the Egyptian economy and its ability to overcome the challenges of an economic and social experience that leads us to the new republic, AstraZeneca Egypt was recognized for our great efforts in being part of the economic nourishment, and our huge contributions in sustainable development of our community.
AstraZeneca Egypt Receives “Sustainability & Supporting Egyptian Economy” Award in a ceremony under the Prime Minister’s Auspices
AZ Egypt was recognized for our efforts in impacting the Egyptian economy through our sustainable development efforts as a pioneer of the pharma industry in Egypt.
Distinguished Leader in Supporting Private-Public Collaborations
AstraZeneca Egypt Country President has been awarded amongst the Arab region as a “Distinguished Leader in Supporting Private-Public Collaborations in Egypt”. This award was granted during the AHDAF conference, where the Arab Hospitals Federation Awards recognize and honor distinguished personalities and healthcare organizations.
Pan Arab Award by the Arab Council for Social Responsibility
In 2022, AstraZeneca Egypt was granted the excellence award “Emtyaz” for our impactful sustainability attainments; our Young Health Programme and the “Partnership for Health System Sustainability and Resilience” during Mogtam3i tech conference.
YHP Award
AstraZeneca Egypt was awarded on the impact of the Young Health Programme emphasizing how the programme comes in line with Egypt Vision 2030 and the Presidential ambition towards reducing NCDs mortality rates by 25%.
AstraZeneca Egypt
Response during COVID-19 pandemic
AstraZeneca, played a pivotal role in the fight against the COVID-19 pandemic, demonstrating its commitment to scientific innovation and societal well-being. The company's unwavering support during this unprecedented crisis manifested in several crucial initiatives. AstraZeneca's most significant contribution was the development of the Oxford-AstraZeneca COVID-19 vaccine, a highly effective and widely accessible vaccine that played a critical role in curbing the spread of the virus and saving countless lives. The company's commitment to equitable access ensured that the vaccine was available to low- and middle-income countries, bridging the global vaccine divide. Beyond vaccine development, AstraZeneca extended its support to healthcare workers, communities, and governments worldwide. The company donated millions of face masks to protect frontline healthcare workers, supported national testing efforts, and actively participated in clinical trials to investigate potential treatments for the virus.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
Patient Safety
In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AstraZeneca Patient Safety Centre:
Phone: +20 2 25980205
Fax: +20 2 5890225
Email: Patient.SafetyEgypt@astrazeneca.com
https://www.contactazmedical.astrazeneca.com
Find Us
Location address: Bureau 58 Business Park,
5th settlement,
New Cairo,
Egypt
Phone: +20 2 2598 0222
Location on maps: AstraZeneca Egypt Office
EG-9188